Research Paper Volume 12, Issue 11 pp 10844—10862

Aberrantly glycosylated integrin α3β1 is a unique urinary biomarker for the diagnosis of bladder cancer

class="figure-viewer-img"

Figure 3. Urinary AG31 levels distinguish between stages and grades of bladder cancer. (A, B) Urinary AG31 levels of bladder cancer patients with different disease stages versus healthy controls in the test groups (A) and in the validation groups (B). (C, D) Urinary AG31 levels of bladder cancer patients with different grades versus healthy controls in the test groups (C) and in the validation groups (D). HC, healthy controls; RLU, relative light unit.